Test Code GUSAP Guselkumab Quantitation with Antibodies, Serum
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.1 mL serum
Collection Instructions:
1. Draw blood immediately before next scheduled dose (trough specimen).
2. Within 2 hours of collection, centrifuge, and aliquot serum into a plastic vial.
Secondary ID
623123Useful For
Evaluation of patients with limited primary (initial) response to or secondary loss of response to guselkumab.
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| GUS | Guselkumab, S | Yes | Yes |
| GUSAB | Guselkumab Ab, S | No | Yes |
Testing Algorithm
For more information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.
Special Instructions
Method Name
GUS: Liquid Chromatography Mass Spectrometry (LC-MS)
GUSAB: Electrochemiluminescent Bridging Immunoassay (ECLIA)
Specimen Type
SerumSpecimen Minimum Volume
Serum: 0.75 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 28 days |
| Frozen | 28 days | |
| Ambient | 24 hours |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
| Heat-treated specimens | Reject |
Reference Values
GUSELKUMAB QUANTITATION:
Guselkumab lower limit of quantitation = 0.5 mcg/mL
ANTIBODIES TO GUSELKUMAB:
<9.8 ng/mL
Interpretation
The presence of detectable anti-guselkumab antibodies may be associated with increased guselkumab clearance and lower circulating concentrations of guselkumab in serum. Low trough concentrations of guselkumab may be correlated with loss of response to the drug.
Method Description
Guselkumab Quantitation:
Guselkumab is extracted from serum and measured by liquid chromatography mass spectrometry.(Unpublished Mayo method)
Guselkumab Antibodies:
Testing for antibodies to guselkumab is accomplished using a laboratory-developed immunoassay.(Unpublished Mayo method)
Day(s) Performed
Weekly
Report Available
2 to 9 daysSpecimen Retention Time
14 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
80299
83520
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| GUSAP | Guselkumab QN with Antibodies, S | In Process |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 622837 | Guselkumab, S | In Process |
| 623122 | Guselkumab Ab, S | In Process |
| 623291 | GUSAB Interpretation | 77202-0 |